NCT00000529View on ClinicalTrials.gov

Tamoxifen Study

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

May 31, 1992

Study Completion Date

November 30, 1995

Conditions

Cardiovascular DiseasesCoronary DiseaseHeart DiseasesHypertensionMyocardial Ischemia

Interventions

DRUG

tamoxifen

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

NSABP Foundation Inc

NETWORK

NCT00000529 - Tamoxifen Study | Biotech Hunter | Biotech Hunter